$TECH
AI分析生成日 May 11, 2026
AI Score
Hold$TECH
Bio-Techne Corporation
$TECHNASDAQHealthcareMid-Cap
Bio-Techne develops and sells biotechnology instruments and reagents for life science research and clinical diagnostics.
Market Cap
$10.0B
Revenue (TTM)
$1.1B
+3.0%
Net Income (TTM)
$0.2B
+5.0%
EPS (TTM)
$1.25
P/E Ratio
52.0
Dividend Yield
0.3%
52-Week Range
$55-$82
Beta
0.92
Dimension Scores
Fundamental
64Technical
62Sentiment
68Risk / Reward
66Momentum
64Financial Health
Profitability
69moderate
Growth
67moderate
Liquidity
74strong
Solvency
66strong
Efficiency
62moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $TECH
Free · No credit card required
免責事項: AI生成の分析は教育目的のみです。投資アドバイスではありません。必ず資格のあるファイナンシャルアドバイザーにご相談ください。